ACH
Accendra Health, Inc.
Price Chart
Latest Quote
$2.27
Current Price| Previous Close | $2.21 |
| Open | $2.20 |
| Day High | $2.38 |
| Day Low | $2.18 |
| Volume | 1,642,735 |
Stock Information
| Shares Outstanding | 77.35M |
| Total Debt | $2.24B |
| Cash Equivalents | $32.84M |
| Revenue | $10.77B |
| Net Income | $-437.05M |
| Sector | Healthcare |
| Industry | Medical Distribution |
| Market Cap | $175.58M |
| EPS (TTM) | $-5.69 |
| Exchange | NYQ |
đ Custom Metrics & Score
Score: 3/42| Debt to Equity | 3.79 |
| Debt to Earnings | 0.96 |
| Current Ratio | 1.08 |
| Quick Ratio | 0.39 |
| Avg Revenue Growth | 2.34% |
| Profit Margin | -3.39% |
| Return on Equity | -64.17% |
| Avg FCF Growth | -47.38% |
| FCF Yield | -37.97% |
Score Explanation: The perfect score is 42/42 based on debt levels, profitability, growth rates, and cash flow metrics. FCF Yield is weighted most heavily as it shows what return the business currently generates.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-02-02 | $2.27 | 1,642,735 |
| 2026-01-30 | $2.21 | 1,308,900 |
| 2026-01-29 | $2.08 | 745,500 |
| 2026-01-28 | $2.12 | 845,500 |
| 2026-01-27 | $2.10 | 1,687,900 |
| 2026-01-26 | $2.03 | 879,000 |
| 2026-01-23 | $2.11 | 1,053,700 |
| 2026-01-22 | $2.11 | 1,324,000 |
| 2026-01-21 | $2.14 | 1,471,700 |
| 2026-01-20 | $2.20 | 1,506,600 |
| 2026-01-16 | $2.52 | 1,545,300 |
| 2026-01-15 | $2.53 | 823,300 |
| 2026-01-14 | $2.58 | 1,053,000 |
| 2026-01-13 | $2.51 | 2,226,500 |
| 2026-01-12 | $2.68 | 1,967,400 |
| 2026-01-09 | $2.46 | 1,801,300 |
| 2026-01-08 | $2.36 | 2,048,900 |
| 2026-01-07 | $2.15 | 3,234,500 |
| 2026-01-06 | $1.91 | 3,325,000 |
| 2026-01-05 | $1.98 | 3,677,400 |
About Accendra Health, Inc.
Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company worldwide. The company operates in two segments, Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, including supplier management, analytics, inventory management, and clinical supply management; and various programs to provide outsourced logistics and marketing solutions to its suppliers. The Patient Direct segment provides products and services for in-home care and delivery across diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment. This segment also supplies a range of other home medical equipment; and patient care products, including ostomy, wound care, urology, and incontinence and other products and services. The company serves multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. Accendra Health, Inc. was formerly known as Owens & Minor, Inc. and changed its name Accendra Health, Inc. in December 2025. The company was founded in 1882 and is based in Glen Allen, Virginia.
đ° Latest News
Asian Equities Traded in the US as American Depositary Receipts Drop Sharply in Tuesday Trading
MT Newswires âĸ 2026-01-20T15:36:31ZAsian Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading
MT Newswires âĸ 2026-01-08T15:39:03ZImplied Volatility Surging for Accendra Health Stock Options
Zacks âĸ 2026-01-08T13:40:00Z
Income Statement (Annual)
Revenue
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Reconciled Cost Of Revenue | $8,481,728,000 | $8,208,806,000 | $8,129,124,000 | $8,272,086,000 |
| Cost Of Revenue | $8,481,728,000 | $8,208,806,000 | $8,129,124,000 | $8,272,086,000 |
| Total Revenue | $10,700,883,000 | $10,333,967,000 | $9,955,475,000 | $9,785,315,000 |
| Operating Revenue | $10,700,883,000 | $10,333,967,000 | $9,955,475,000 | $9,785,315,000 |
Expenses
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Interest Expense | $143,804,000 | $157,915,000 | $128,891,000 | $48,090,000 |
| Total Expenses | $10,404,835,000 | $10,029,295,000 | $9,678,693,000 | $9,342,959,000 |
| Other Income Expense | $-509,601,000 | $-201,483,000 | $-137,000,000 | $-117,512,000 |
| Other Non Operating Income Expenses | $-4,683,000 | $-4,837,000 | $-3,131,000 | $-3,196,000 |
| Net Non Operating Interest Income Expense | $-143,804,000 | $-157,915,000 | $-128,891,000 | $-48,090,000 |
| Interest Expense Non Operating | $143,804,000 | $157,915,000 | $128,891,000 | $48,090,000 |
| Operating Expense | $1,923,107,000 | $1,820,489,000 | $1,549,569,000 | $1,070,873,000 |
| Other Operating Expenses | $13,316,000 | $6,930,000 | $-5,252,000 | $-6,191,000 |
Income & Earnings
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Income From Continuing Operation Net Minority Interest | $-362,686,000 | $-41,301,000 | $22,389,000 | $221,589,000 |
| Net Interest Income | $-143,804,000 | $-157,915,000 | $-128,891,000 | $-48,090,000 |
| Normalized Income | $36,199,220 | $107,166,730 | $128,145,510 | $313,156,116 |
| Net Income From Continuing And Discontinued Operation | $-362,686,000 | $-41,301,000 | $22,389,000 | $221,589,000 |
| Total Operating Income As Reported | $-207,769,000 | $104,508,000 | $142,913,000 | $368,473,000 |
| Net Income Common Stockholders | $-362,686,000 | $-41,301,000 | $22,389,000 | $221,589,000 |
| Net Income | $-362,686,000 | $-41,301,000 | $22,389,000 | $221,589,000 |
| Net Income Including Noncontrolling Interests | $-362,686,000 | $-41,301,000 | $22,389,000 | $221,589,000 |
| Net Income Continuous Operations | $-362,686,000 | $-41,301,000 | $22,389,000 | $221,589,000 |
| Pretax Income | $-357,357,000 | $-54,726,000 | $10,891,000 | $276,754,000 |
| Special Income Charges | $-504,918,000 | $-196,646,000 | $-133,869,000 | $-114,316,000 |
| Operating Income | $296,048,000 | $304,672,000 | $276,782,000 | $442,356,000 |
| Gross Profit | $2,219,155,000 | $2,125,161,000 | $1,826,351,000 | $1,513,229,000 |
| Net Income Discontinuous Operations | - | - | $0 | $0 |
Per Share Metrics
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Diluted EPS | $-4.73 | $-0.54 | $0.29 | $2.94 |
| Basic EPS | $-4.73 | $-0.54 | $0.30 | $3.05 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Tax Effect Of Unusual Items | $-106,032,780 | $-48,178,270 | $-28,112,490 | $-22,748,884 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $556,140,000 | $587,212,000 | $502,318,000 | $529,781,000 |
| Total Unusual Items | $-504,918,000 | $-196,646,000 | $-133,869,000 | $-114,316,000 |
| Total Unusual Items Excluding Goodwill | $-504,918,000 | $-196,646,000 | $-133,869,000 | $-114,316,000 |
| Reconciled Depreciation | $264,775,000 | $287,377,000 | $228,667,000 | $90,621,000 |
| EBITDA (Bullshit earnings) | $51,222,000 | $390,566,000 | $368,449,000 | $415,465,000 |
| EBIT | $-213,553,000 | $103,189,000 | $139,782,000 | $324,844,000 |
| Diluted Average Shares | $76,741,000 | $75,785,000 | $76,217,000 | $75,486,000 |
| Basic Average Shares | $76,741,000 | $75,785,000 | $74,496,000 | $72,744,000 |
| Diluted NI Availto Com Stockholders | $-362,686,000 | $-41,301,000 | $22,389,000 | $221,589,000 |
| Tax Provision | $5,329,000 | $-13,425,000 | $-11,498,000 | $55,165,000 |
| Other Special Charges | $1,101,000 | $-3,518,000 | - | $40,433,000 |
| Impairment Of Capital Assets | $307,112,000 | $0 | $0 | - |
| Restructuring And Mergern Acquisition | $196,705,000 | $200,164,000 | $133,869,000 | $73,883,000 |
| Selling General And Administration | $1,909,791,000 | $1,813,559,000 | $1,554,821,000 | $1,077,064,000 |
Balance Sheet (Annual)
Assets
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Tangible Assets | $-1,062,781,000 | $-1,076,515,000 | $-1,136,143,000 | $338,571,000 |
| Total Assets | $4,656,156,000 | $5,093,322,000 | $5,386,283,000 | $3,536,551,000 |
| Total Non Current Assets | $2,633,139,000 | $2,990,532,000 | $3,091,098,000 | $1,214,739,000 |
| Other Non Current Assets | $140,158,000 | $149,346,000 | $150,417,000 | $103,568,000 |
| Goodwill And Other Intangible Assets | $1,628,007,000 | $2,000,681,000 | $2,081,747,000 | $599,930,000 |
| Other Intangible Assets | $296,726,000 | $361,835,000 | $445,042,000 | $209,745,000 |
| Current Assets | $2,021,017,000 | $2,102,790,000 | $2,295,185,000 | $2,321,812,000 |
| Other Current Assets | $149,515,000 | $150,890,000 | $128,636,000 | $88,564,000 |
| Inventory | $1,131,879,000 | $1,110,606,000 | $1,333,585,000 | $1,495,972,000 |
| Receivables | $690,241,000 | $598,257,000 | $763,497,000 | $681,564,000 |
| Accounts Receivable | $690,241,000 | $598,257,000 | $763,497,000 | $681,564,000 |
| Allowance For Doubtful Accounts Receivable | $-6,200,000 | $-7,900,000 | $-9,100,000 | $-18,000,000 |
| Gross Accounts Receivable | $696,441,000 | $606,157,000 | $772,597,000 | $699,564,000 |
| Cash Cash Equivalents And Short Term Investments | $49,382,000 | $243,037,000 | $69,467,000 | $55,712,000 |
| Cash And Cash Equivalents | $49,382,000 | $243,037,000 | $69,467,000 | $55,712,000 |
Debt
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Debt | $1,789,733,000 | $1,854,465,000 | $2,431,407,000 | $891,828,000 |
| Total Debt | $2,139,808,000 | $2,319,931,000 | $2,716,343,000 | $1,109,781,000 |
| Long Term Debt And Capital Lease Obligation | $2,094,608,000 | $2,113,027,000 | $2,698,437,000 | $1,109,781,000 |
| Long Term Debt | $1,799,115,000 | $1,890,598,000 | $2,482,968,000 | $947,540,000 |
| Current Debt And Capital Lease Obligation | $45,200,000 | $206,904,000 | $17,906,000 | - |
| Current Debt | $40,000,000 | $206,904,000 | $17,906,000 | - |
| Other Current Borrowings | $40,000,000 | - | - | - |
Liabilities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Liabilities Net Minority Interest | $4,090,930,000 | $4,169,156,000 | $4,440,679,000 | $2,598,050,000 |
| Total Non Current Liabilities Net Minority Interest | $2,217,191,000 | $2,277,271,000 | $2,874,213,000 | $1,254,029,000 |
| Other Non Current Liabilities | $100,127,000 | $122,592,000 | $114,943,000 | $108,938,000 |
| Non Current Deferred Liabilities | $22,456,000 | $41,652,000 | $60,833,000 | $35,310,000 |
| Non Current Deferred Taxes Liabilities | $22,456,000 | $41,652,000 | $60,833,000 | $35,310,000 |
| Current Liabilities | $1,873,739,000 | $1,891,885,000 | $1,566,466,000 | $1,344,021,000 |
| Other Current Liabilities | $425,536,000 | $396,701,000 | $307,850,000 | $226,204,000 |
| Payables And Accrued Expenses | $1,403,003,000 | $1,288,280,000 | $1,240,710,000 | $1,117,817,000 |
| Payables | $1,251,964,000 | $1,171,882,000 | $1,147,414,000 | $1,001,959,000 |
| Accounts Payable | $1,251,964,000 | $1,171,882,000 | $1,147,414,000 | $1,001,959,000 |
Equity
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Common Stock Equity | $565,226,000 | $924,166,000 | $945,604,000 | $938,501,000 |
| Total Equity Gross Minority Interest | $565,226,000 | $924,166,000 | $945,604,000 | $938,501,000 |
| Stockholders Equity | $565,226,000 | $924,166,000 | $945,604,000 | $938,501,000 |
| Gains Losses Not Affecting Retained Earnings | $-49,344,000 | $-31,818,000 | $-35,855,000 | $-40,591,000 |
| Other Equity Adjustments | $-49,344,000 | $-31,818,000 | $-35,855,000 | $-40,591,000 |
| Retained Earnings | $6,021,000 | $368,707,000 | $410,008,000 | $387,619,000 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Ordinary Shares Number | $77,199,000 | $76,546,000 | $76,279,000 | $75,433,000 |
| Share Issued | $77,199,000 | $76,546,000 | $76,279,000 | $75,433,000 |
| Tangible Book Value | $-1,062,781,000 | $-1,076,515,000 | $-1,136,143,000 | $338,571,000 |
| Invested Capital | $2,404,341,000 | $3,021,668,000 | $3,446,478,000 | $1,886,041,000 |
| Working Capital | $147,278,000 | $210,905,000 | $728,719,000 | $977,791,000 |
| Capital Lease Obligations | $300,693,000 | $222,429,000 | $215,469,000 | $162,241,000 |
| Total Capitalization | $2,364,341,000 | $2,814,764,000 | $3,428,572,000 | $1,886,041,000 |
| Additional Paid In Capital | $454,151,000 | $434,185,000 | $418,894,000 | $440,608,000 |
| Capital Stock | $154,398,000 | $153,092,000 | $152,557,000 | $150,865,000 |
| Common Stock | $154,398,000 | $153,092,000 | $152,557,000 | $150,865,000 |
| Long Term Capital Lease Obligation | $295,493,000 | $222,429,000 | $215,469,000 | $162,241,000 |
| Current Capital Lease Obligation | $5,200,000 | - | - | - |
| Current Accrued Expenses | $151,039,000 | $116,398,000 | $93,296,000 | $115,858,000 |
| Goodwill | $1,331,281,000 | $1,638,846,000 | $1,636,705,000 | $390,185,000 |
| Net PPE | $864,974,000 | $840,505,000 | $858,934,000 | $511,241,000 |
| Accumulated Depreciation | $-565,119,000 | $-546,397,000 | $-450,286,000 | $-334,500,000 |
| Gross PPE | $1,430,093,000 | $1,386,902,000 | $1,309,220,000 | $845,741,000 |
| Construction In Progress | $32,185,000 | $10,728,000 | $14,400,000 | $25,637,000 |
| Other Properties | $744,072,000 | $658,725,000 | $604,672,000 | $194,006,000 |
| Machinery Furniture Equipment | $472,590,000 | $492,551,000 | $470,071,000 | $431,836,000 |
| Buildings And Improvements | $171,870,000 | $201,939,000 | $197,228,000 | $171,268,000 |
| Land And Improvements | $9,376,000 | $22,959,000 | $22,849,000 | $22,994,000 |
| Properties | $0 | $0 | $0 | $0 |
| Inventories Adjustments Allowances | $-64,956,000 | $-78,185,000 | - | - |
| Finished Goods | $1,059,798,000 | $1,051,553,000 | $1,333,585,000 | $1,495,972,000 |
| Work In Process | $59,115,000 | $61,527,000 | - | - |
| Raw Materials | $77,922,000 | $75,711,000 | - | - |
Cash Flow Statement (Annual)
Free Cash Flow
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | $-66,667,000 | $532,818,000 | $158,424,000 | $74,487,000 |
Operating Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Operating Cash Flow | $161,495,000 | $740,710,000 | $325,006,000 | $124,177,000 |
| Cash Flow From Continuing Operating Activities | $161,495,000 | $740,710,000 | $325,006,000 | $124,177,000 |
| Operating Gains Losses | $-43,604,000 | $-38,400,000 | $-26,260,000 | $40,433,000 |
Investing Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Capital Expenditure | $-228,162,000 | $-207,892,000 | $-166,582,000 | $-49,690,000 |
| Investing Cash Flow | $-116,533,000 | $-137,254,000 | $-1,804,476,000 | $-53,630,000 |
| Cash Flow From Continuing Investing Activities | $-116,533,000 | $-137,254,000 | $-1,804,476,000 | $-53,630,000 |
| Net Other Investing Changes | $8,203,000 | $-936,000 | $-1,670,000 | $-3,940,000 |
Financing Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Financing Cash Flow | $-267,603,000 | $-417,330,000 | $1,497,105,000 | $-129,478,000 |
| Cash Flow From Continuing Financing Activities | $-267,603,000 | $-417,330,000 | $1,497,105,000 | $-129,478,000 |
| Net Other Financing Charges | $-23,406,000 | $-637,000 | $-85,395,000 | $-31,873,000 |
| Cash Dividends Paid | - | $0 | $0 | $-731,000 |
| Common Stock Dividend Paid | - | $0 | $0 | $-731,000 |
| Issuance Of Capital Stock | - | - | $0 | $0 |
| Net Common Stock Issuance | - | - | $0 | $0 |
| Common Stock Issuance | - | - | $0 | $0 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Repayment Of Debt | $-2,345,797,000 | $-892,693,000 | $-1,160,800,000 | $-553,140,000 |
| Issuance Of Debt | $2,101,600,000 | $476,000,000 | $2,743,300,000 | $574,900,000 |
| Interest Paid Supplemental Data | $141,547,000 | $153,247,000 | $107,022,000 | $38,717,000 |
| Income Tax Paid Supplemental Data | $5,553,000 | $6,283,000 | $33,973,000 | $99,400,000 |
| End Cash Position | $49,382,000 | $272,924,000 | $86,185,000 | $72,035,000 |
| Beginning Cash Position | $272,924,000 | $86,185,000 | $72,035,000 | $134,506,000 |
| Effect Of Exchange Rate Changes | $-901,000 | $613,000 | $-3,485,000 | $-3,540,000 |
| Changes In Cash | $-222,641,000 | $186,126,000 | $17,635,000 | $-58,931,000 |
| Net Issuance Payments Of Debt | $-244,197,000 | $-416,693,000 | $1,582,500,000 | $-81,440,000 |
| Net Long Term Debt Issuance | $-244,197,000 | $-416,693,000 | $1,582,500,000 | $21,760,000 |
| Long Term Debt Payments | $-2,345,797,000 | $-892,693,000 | $-1,160,800,000 | $-553,140,000 |
| Long Term Debt Issuance | $2,101,600,000 | $476,000,000 | $2,743,300,000 | $574,900,000 |
| Net Business Purchase And Sale | $0 | $0 | $-1,684,607,000 | $0 |
| Purchase Of Business | $0 | $0 | $-1,684,607,000 | $0 |
| Net Intangibles Purchase And Sale | $-17,297,000 | $-17,022,000 | $-8,492,000 | $-8,705,000 |
| Purchase Of Intangibles | $-17,297,000 | $-17,022,000 | $-8,492,000 | $-8,705,000 |
| Net PPE Purchase And Sale | $-107,439,000 | $-119,296,000 | $-109,707,000 | $-40,985,000 |
| Sale Of PPE | $103,426,000 | $71,574,000 | $48,383,000 | $0 |
| Purchase Of PPE | $-210,865,000 | $-190,870,000 | $-158,090,000 | $-40,985,000 |
| Change In Working Capital | $-25,438,000 | $520,872,000 | $93,083,000 | $-261,400,000 |
| Change In Other Working Capital | $30,153,000 | $100,370,000 | $-91,544,000 | $692,000 |
| Change In Payables And Accrued Expense | $65,187,000 | $30,997,000 | $13,652,000 | $3,548,000 |
| Change In Payable | $65,187,000 | $30,997,000 | $13,652,000 | $3,548,000 |
| Change In Account Payable | $65,187,000 | $30,997,000 | $13,652,000 | $3,548,000 |
| Change In Inventory | $-26,228,000 | $224,338,000 | $166,559,000 | $-263,439,000 |
| Change In Receivables | $-94,550,000 | $165,167,000 | $4,416,000 | $-2,201,000 |
| Changes In Account Receivables | $-94,550,000 | $165,167,000 | $4,416,000 | $-2,201,000 |
| Other Non Cash Items | $20,615,000 | $12,592,000 | $12,495,000 | $16,496,000 |
| Stock Based Compensation | $26,836,000 | $23,218,000 | $20,993,000 | $25,016,000 |
| Asset Impairment Charge | $307,112,000 | $0 | $0 | $0 |
| Deferred Tax | $-26,115,000 | $-23,648,000 | $-26,361,000 | $-29,736,000 |
| Deferred Income Tax | $-26,115,000 | $-23,648,000 | $-26,361,000 | $-29,736,000 |
| Depreciation Amortization Depletion | $264,775,000 | $287,377,000 | $228,667,000 | $90,621,000 |
| Depreciation And Amortization | $264,775,000 | $287,377,000 | $228,667,000 | $90,621,000 |
| Gain Loss On Sale Of PPE | $-44,705,000 | $-34,882,000 | $-26,260,000 | $0 |
| Net Income From Continuing Operations | $-362,686,000 | $-41,301,000 | $22,389,000 | $221,589,000 |
| Proceeds From Stock Option Exercised | - | $0 | $0 | $-15,434,000 |
| Net Short Term Debt Issuance | - | $0 | $30,000,000 | $-103,200,000 |
| Provisionand Write Offof Assets | - | $-1,414,000 | $3,315,000 | $21,158,000 |
| Interest Paid Cff | - | - | $-42,602,000 | $-13,912,000 |
| Sale Of Business | - | - | $0 | $0 |
| Gain Loss On Sale Of Business | - | - | $0 | $0 |
| Short Term Debt Payments | - | - | - | $-103,200,000 |